baber/WOPTO huggingface dataset:
Patent NZ-234957-A (NZ)
Title: Method of treating skin and mucosal diseases using a serotonin antagonist
Inventor: SHARPE RICHARD J
IPC: A61P31/04
Filed: 1990-08-17
Abstract: A method and composition for the topical treatment of cutaneous, mucosal or ocular hypersensitivity reactions, inflammation, or epithelial hyperproliferative states, including those associated with scarring. The composition, to be applied directly to an affected area of the skin, eye, or mucosal membrane, consists of a therapeutic amount of reserpine, spiperone, or other serotonin antagonist which has been incorporated into a vehicle suitable for topical administration.
Patent NZ-256548-A (NZ)
Title: Process for cleaning up a water insoluble coating composition by adjusting the ph and washing
Inventor: PENNAZ THOMAS J
IPC: C09D7/00
Filed: 1993-09-15
Abstract: An ink composition incorporating a water reducible resin which is water insoluble under certain conditions and selectively water washable under certain other conditions. The method aspect of the present invention relates to a method of making, using and recovering the ink composition.
Patent NZ-275078-A (NZ)
Title: Light propogation within biological matrix determines glucose concentration
Inventor: ESSENPREIS MATTHIAS
IPC: G01N21/47
Filed: 1994-10-29
Abstract: PCT No. PCT/DE94/01290 Sec. 371 Date Feb. 9, 1996 Sec. 102(e) Date Feb. 9, 1996 PCT Filed Oct. 29, 1994 PCT Pub. No. WO95/12348 PCT Pub. Date May 11, 1995Method and apparatus for the analytical determination of glucose concentration in a biological matrix, wherein in a detection step light from a light emitter is irradiated into the biological matrix as primary light via a boundary surface of the biological matrix and light emerging from the the biological matrix through a boundary surface is being detected by a light detector in order to determine a measurable physical light property which is changed by interaction with the biological matrix and which correlates with the glucose concentration of said matrix. The glucose concentration is ascertained in an evaluation step on the basis of said change of the physical light property determined in at least one detection step in comparison with a calibration. In order to achieve by such a method good analytical accuracy in reagent-free and non-invasive manner, for instance to observe the change of the concentration of the analyzed substance (monitoring) over an adequate time interval, a measurable parameter corresponding to the light transit-time within the biological matrix between a defined irradiation site and a defined detection site and correlating with the glucose concentration is determined in the detection step.
Patent NZ-283944-A (NZ)
Title: Mass transfer/exchange column with vapour-contact tray and downcomer assembly having louvres to give horizontal flow to liquid exiting the downcomer and/or vapour passing the tray
Inventor: YEOMAN NEIL
IPC: B01D3/24
Filed: 1995-04-06
Abstract: A vapor-liquid contact tray and downcomer assembly is provided with louvres which serve to impart a horizontal directional flow to the liquid exiting the downcomer and/or the vapor passing through the tray. The downcomer includes a bottom plate which closes the outlet region of the downcomer and includes a plurality of louvres presenting generally vertical openings in the direction of liquid flow across the underlying tray. The downcomer receiving area in the underlying tray can include similar louvres. The louvres redirect the vertical momentum of the liquid and vapor streams to a generally horizontal momentum as the liquid exits the downcomer and as the vapor rises through the tray. In other embodiments, the louvres in either the bottom plate or the downcomer receiving area of the tray are replaced with apertures which do not block the vertical momentum of the stream passing through the apertures. An enhanced vapor-liquid active area on the tray results from the use of the louvres.
Patent NZ-313199-A (NZ)
Title: Marine navigation device using two pivoting discs and rules to determine position on chart from GPS data
Inventor: GOSSELIN FRANCIS
IPC: G09B29/10
Filed: 1996-07-02
Abstract: A device for determining a position on a navigational chart on the basis of GPS data, comprising a rapid orientation and positioning assembly having two discs arranged one on top of the other and used as a protractor and a reader, respectively, said discs being pivotably joined together in the middle by a pointing means and two positioning rules. The upper rule is also used for orientation and both rules have a central longitudinal aperture while the edges of the rules include a projection enabling each rule to slide freely along a respective mortised recess in each disc. The upper rule is provided with a double longitudinal scale. Said device is particularly useful as an aid for work on navigational charts.
Patent NZ-314698-A (NZ)
Title: Preparation of bifurcated stents (devices for implanting within body cavities)
Inventor: RICHTER JACOB
IPC: A61F2/06
Filed: 1997-04-29
Abstract: A bifurcated stent for insertion into a bifurcated vessel such as a blood vessel. In one embodiment, a first sheet is formed into a first leg, a second sheet is formed into a second leg, a third sheet is formed into a stem, and the two legs are attached to the stem. In a second embodiment, a first sheet is formed into a member having a first leg and half of a stem, a second sheet is formed into a second member having a second leg and half of a stem, and the two stem halves are combined to form the bifurcated stent. In a third embodiment, the stent comprises two sections that are serially inserted and assembled within the vessel at the site of the bifurcation to be treated.
Patent NZ-334453-A (NZ)
Title: Tricyclic inhibitors of farnesyl protein transferase
Inventor: TAVERAS ARTHUR G
IPC: A61K31/496
Filed: 1997-09-11
Abstract: The compounds of formula I are inhibitors of farnesyl protein transferase.  They can be used to inhibit the growth of abnormal cells, such as tumor cells. In compound I: One of a, b, c and d represents N or NR9, and the remaining a, b, c and d groups represent CR1 or CR2; or each of a, b, c, and d are independently selected from CR1 or CR2; R1 and R2 are independently selected from H, halo, CF3, OR10, COR10, SR10, S(O)tR11(wherein t is 0-2), SCN, N(R10)2, NR10R11, NO2, OC(O)R10, C02R10, OCO2R11, CN, NHC(O)R10, NHSO2R10, CONHR10, CONHCH2CH2OH, NR10COOR11, SR11C(O)OR11 or SR11N(R75)2; R3 and R4 are the same or different and each independently represents H or any of the substituents of R1 and R2; or R3 and R4 taken together represent a saturated or unsaturated C5-C7 fused ring to the benzene ring (Ring III); R5, R6, R7 and R8 each independently represents H, CF3, COR10, alkyl or aryl optionally substituted with OR10, SR10, S(O)tR11, NR10COOR11, N(R10)2, NO2, COR10, OCOR10, OCO2R11, C02R10, OPO3R10 or R5 is combined with R6 to represent =0 or =S and/or R7 is combined with R8 to represent =0 or =S; X represents N, CH or C, which C may contain an optional double bond (represented by the dotted line) to carbon atom 11; the dotted line between carbon atoms 5 and 6 represents an optional double bond, such that when a double bond is present. A and B independently represent R10, halo, OR11, OC02R11 or OC(O)R10, and when no double bond is present between carbon atoms 5 and 6, A and B each independently represent H2, (OR11)2; H and halo, dihalo, alkyl and H, (alkyl)2, H and OC(O)R10, H and OR10, =0, aryl and H, =NOR10 or O(CH2)pO, wherein p is 2, 3 or 4; W represents a heteroaryl, aryl, heterocyloalkyl or cycloalkyl group; R9 is O, CH3 or (CH2)nCO2H wherein n is 1 to 3 R10 represents H, alkyl, aryl, or aralkyl; R11 represents alkyl or aryl; and R75 is independently selected from H and C(O)OR11, benzotriazol-1-yloxy, tetrazol-5ylthio, or substituted tetrazol-5-ylthio, alkynyl, alkenyl or alkyl, said alkyl or alkenyl group optionally being substituted with halo, -OR10 or -C02R10.
Patent NZ-334681-A (NZ)
Title: Annular diffuser, for a wind turbine, assembled from arcuate segments by lifting alternate ends and attaching segments
Inventor: CORKERY MAURICE ANTHONY
IPC: F03D1/04
Filed: 1999-03-17
Abstract: A diffuser for a diffuser augmented turbine is assembled by lifting an end of segment, attaching another segment, and then lifting the resulting assembly, and attaching another segment. This procedure is repeated until the diffuser is assembled.
Patent NZ-334854-A (NZ)
Title: Foliar fertilisers including trace element compounds
Inventor: BULL BARRETT CLIFFORD
IPC: C05G5/23
Filed: 1997-09-29
Abstract: A foliar fertiliser composition providing for consistent enhancement of a crop characteristic in a crop includes soluble compounds of the following trace elements in the following ranges of relative proportions of the respective element by weight: 0.5 to 4.0 copper, 2.0 to 10.0 zinc, 2.5 to 12 manganese, 5 to 14.0 iron, 0.5 to 6.5 boron, 0 to 0.3 molybdenum.  Citric acid may be used to stabilize the composition.
Patent NZ-335200-A (NZ)
Title: Plant for transferring liquid metal, method of operation, and refractories
Inventor: RICHARD FRANCOIS-NOEL
IPC: B22D41/50
Filed: 1997-10-15
Abstract: he invention relates to a plant for transferring liquid metal, in particular steel, between an upstream container (2) and a downstream container (10).  The plant comprises an upstream container (2), a tapping spout (28), a downstream container (10), a flow regulator (26) for regulating the flow of liquid metal through the tapping spout (28) and a set of refractory assemblies (8, 12, 30, 32, 64, 66, 74) which are placed between the upstream container and the downstream container, delimiting the tapping spout (28) via which the liquid metal flows from the upstream container (2) into the downstream container (10).  Each refractory assembly of the tapping spout (28) has at least one mating surface (22) forming a joint with a corresponding surface of an adjacent refractory assembly.  A shroud channel (18) is placed around the tapping spout (28) near at least one mating surface (22) between refractory assemblies (8, 12).  Plant means (24) are provided for introducing a sealing agent into shroud channel (18).
Patent NZ-335328-A (NZ)
Title: Transcription regulatory elements such as FGF-inducible response element (FiRE) associated with syndecan-1 gene
Inventor: JALKANEN MARKKU
IPC: C07K14/705
Filed: 1997-12-02
Abstract: A purified DNA molecule consisting of a syndecan enhancer element, wherein the syndecan enhancer element are inducible by FGF-2 (fibroblast growth factors-2), FGF-7, EGF and/or TGFa factors. The polypeptides derived are capable of activating the enhancer element which is linked to a structural gene, and the use may regulate the expression of syndecan-1 genes. The enhancer element can also be used to target expression of a gene to repair wound sites.
Patent NZ-500121-A (NZ)
Title: Reduction of aliasing in 3D images by multiple small shifts of pixel values.
Inventor: SASAKI NOBUO
IPC: G06T15/00
Filed: 1999-10-06
Abstract: Pixel data to be output to a two dimensional display device is stored in a pixel data memory.  A shift setting processor sets multiple shift amounts for shifting a drawing position on the pixel data memory with a precision finer than one pixel.  A drawing processor overwrites the image by drawing the pixel data in each position of the pixel data memory corresponding to the multiple shift amounts set by the shift setting processor.  Aliasing of the images presented in a gaming machine display may be reduced using this overwriting technique.
Patent NZ-503057-A (NZ)
Title: Wool harvesting system and related methods
Inventor: STOCKWELL PETER ROBERT
IPC: A01K13/00
Filed: 1998-08-21
Abstract: A wool harvesting system and related equipment including a net (14) for retention of fleece (13) in a controlled manner upon a sheep (11) during a biological defleecing operation, and handling systems including a coat and a handling table. The above described components and systems are utilised in conjunction with specified treatments including the preparation of a carcass with skin on.
Patent NZ-503078-A (NZ)
Title: Caenorhabditis elegans gro-1 gene and human homologue
Inventor: LEMIEUX JASON
IPC: C12N9/10
Filed: 1998-08-20
Abstract: Described is the identification of gro-1 gene and demonstrated is that the gro-1 gene is involved in the control of a central physiological clock.  Also disclosed are four other genes located within the same operon as the gro-1 gene.
Patent NZ-506720-A (NZ)
Title: Histamine H3 receptor ligands
Inventor: KALINDJIAN SARKIS BARRET
IPC: C07D405/12
Filed: 1999-02-15
Abstract: A compound of formula (I) where; A is (CH2)m, m being from 1 to 3; B is (CH2)n, n being from 1 to 3; x is from 0 to 2; R1 is C1 to C10 hydrocarbyl, in which up to 2 carbon atoms may be replaced by 0, S, or N, and up to 2 hydrogen atoms may be replaced by halogen; R2 is H or C1 to C15 hydrocarbyl, in which up to 3 carbon atoms may be replaced by O, S, or N, and up to 3 hydrogen atoms may be replaced by halogen; R3 is absent when -Y-Z-R2 is attached to W, or is H or C1 to C7 hydrocarbyl when -Y-Z-R2 is not attached to W; W is nitrogen; X is -CH2-, -O- or -NR4-, R4 being H or C1 to C3 alkyl; Y replaces a hydrogen atom on any of A, B, W and X, and is C2 to C10 alkylene, in which one non-terminal carbon atom may be replaced by O; and Z is a compound of formula (a)-(f) where R5, R6 and R7 are independently H or C1 to C15 hydrocarbyl, in which up to 3 carbon atoms may be replaced by O or N, and up to 3 hydrogen atoms may be replaced by halogen, and Q is H or methyl, or Q is linked to R5 or R7 to form a five-membered ring or Q is linked to R2 to form a six-membered ring, providing that; where Z is of formula (g) at least one of R5 and R7 is aryl(C1 to C3)alkyl or cycloalkyl(C1 to C3)alkyl, optionally substituted by halo. Also described is a pharmaceutical composition comprising a therapeutically effective amount of such a compound and a method for making these compounds.
Patent NZ-509293-A (NZ)
Title: 5-Thia-omega-substituted phenyl-prostaglandin E derivatives
Inventor: MARUYAMA TORU
IPC: C07C405/00
Filed: 1999-07-14
Abstract: A 5-thia-w-substituted phenyl prostaglandin E derivative of the formula  I, a wherein R1 is hydroxy, C1-6 alkyloxy or NR6R7 (in which R6 and R7 is, each independently, hydrogen or C 1-4 alkyl), R2 is oxo, halogen or O-COR8 (in which R8 is C1-4 alkyl, phenyl or phenyl (C1-4 alkyl)), R3 is hydrogen or hydroxy R4a and R4b is, each independently, hydrogen or C1-4 alkyl R5 is a substituted phenyl The compounds of this formula can bind strongly to PGE receptors and may therefore be useful in prevention or treatment of a range of diseases including immunological diseases (such as multiple sclerosis), asthma, hypertension and acute hepatitis.
Patent NZ-517409-A (NZ)
Title: RP-II properties with amino acid substitutions used in detergent compositions and additives
Inventor: NORREGAARD-MADSEN MADS
IPC: C12N9/56
Filed: 2000-08-31
Abstract: Described are isolated proteases of the RP-II type and variants of RP-II proteases exhibiting improved properties in comparison to the parent RP-II protease, DNA constructs and vectors coding for the expression of the proteases and variants, host cells capable of expressing the proteases and variants from the DNA constructs, as well as a method of producing them by cultivating said host cells. The proteases may be used advantageously as constituents in detergent compositions and additives, optionally in combination with other enzymes such as other proteases, lipases, cellulases, amylases, peroxidases or oxidases.
Patent NZ-517604-A (NZ)
Title: Use of Docetaxel in the manufacture of a medicament for treating hepatoma
Inventor: CHI CHIN-WEN
IPC: A61K31/00
Filed: 2000-08-29
Abstract: The use of docetaxel or a hydrate for the manufacture of a medicament for the treatment of hepatocellular carcinoma.
Patent NZ-518296-A (NZ)
Title: N-phenyl-1,2-dihydro-2-oxo-quinoline-3-carboxamide derivatives and their use in the treatment of breast and prostatic cancer
Inventor: HEDLUND GUNNAR
IPC: C07D215/54
Filed: 2000-10-24
Abstract: The compounds of general formula (I) are useful for the treatment of breast and prostatic cancer. In the compound of formula (I): A is OR41 or NR42R4; R is hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl or allyl; with the proviso that R is not hydrogen when A is OR41; R' is hydrogen, methyl, methoxy, fluoro, chloro, bromo, cyano, trifluoromethyl or OCHxFy, where x = 0-2 and y = 1-3 with the proviso that x+y=3; and with the proviso that R' is not hydrogen when R is methyl and A is OR41; R" is hydrogen, fluoro or chloro, with the proviso that R" is selected from fluoro and chloro only when R' is selected from fluoro and chloro; R5 is hydrogen, methyl, ethyl, n-propyl. iso-propyl, methoxy, ethoxy, fluoro, chloro. bromo, trifluoromethyl, dimethylamino, OCHxFy, or OCH2CHxFy, where x = 0-2 and y = 1-3 with the proviso that x+y=3; with the further provisos that R5 is not fluoro when A is OR41; and that R5 is hydrogen only when A is NR42R43 and R' is trifluoromethyl; R6 is hydrogen; or R5 and R6 taken together are methylenedioxy.  Certain compounds of formula (I) and pharmaceutical compositions thereof are also described.
Patent NZ-524199-A (NZ)
Title: Antibodies to human IL-1beta
Inventor: GRAM HERMANN
IPC: A61P31/04
Filed: 2001-08-20
Abstract: An IL-1beta binding molecule, such as a human antibody, comprising both heavy (vH) and light chain (VL) variable domains in which said IL-1beta binding molecule comprises at least one antigen binding site comprising: (a) an immunoglobulin heavy chain variable domain which comprises in sequence hypervariable regions CDR1, CDR2 and CDR3, said CDR1 having the amino acid sequence Val-Tyr-Gly-Met-Asn (VYGMN), said CDR2 having the amino acid sequence Ile-Ile-Trp-Tyr-Asp-Gly-Asp-Asn-Gln-Tyr-Tyr-Ala-Asp-Ser-Val-Lys-Gly (IIWYDGDNQYYADSVKG), and said CDR3 having the amino acid sequence Asp-Leu-Arg-Thr-Gly-Pro (DLRTGP); and (b) an immunoglobulin light chain variable domain which comprises in sequence hypervariable regions CDR1', CDR2' and CDR3', said CDR1' having the amino acid sequence Arg-Ala-Ser-Gln-Ser-Ile-Gly-Ser-Ser-Leu-His (RASQSIGSSLH), said CDR2' having the amino acid sequence Ala-Ser-Gln-Ser-Phe-Ser (ASQFS), and said CDR3' having the amino acid sequence His-Gln-Ser-Ser-Leu-Pro (HQSSLP); and direct equivalents thereof.
Patent NZ-525289-A (NZ)
Title: Mixed cultures for improved fermentation and aerobic stability of silage
Inventor: CHAN RUSSELL KUO-FU
IPC: A23K1/00
Filed: 2001-10-31
Abstract: A silage inoculant, comprising an isolated and purified combination of: * a viable culture of a homofermentive lactic acid bacteria, and * a viable culture of a heterofermentive lactic acid bacteria. The homofermentive lactic acid bacteria is Lactobacillus plantarum and the heterofermentive lactic acid bacteria is Lactobacillus buchneri or Lactobacillus brevis. The ratio of viable cells of the homofermentive lactic acid bacteria to the heterofermentive lactic acid bacteria ranges from about 1: 5 to about 1: 15.
Patent NZ-526518-A (NZ)
Title: Interlocking building block
Inventor: BOTT TIMOTHY A
IPC: E04B2/02
Filed: 2003-06-16
Abstract: The present building block has at least one inner core, a secondary or end core portion, and an interlock protruding from one face and forming a portion of the periphery of at least one of the inner cores. When placed end to end and at the same level, building blocks form a secondary core or seat for reception of the interlock. When a first row of building blocks placed end to end is staggered relative to a second row of building blocks placed end to end, the interlocks of one row of building blocks mate with the secondary or end core portions or relatively large inner cores of the other row of building blocks such that neighboring rows of building block interlock. The basic building block has ends that are oblique such that rows having a preset radius can be formed or such that a linear row can be formed by placing one block front-to-back and an adjacent building block back-to-front.
Patent NZ-532352-A (NZ)
Title: Container and assembly thereof
Inventor: PICKERING DENIS PETER
IPC: B31B11/00
Filed: 2004-04-16
Abstract: Apparatus and methods for forming multiple different types of containers are disclosed. The apparatus (100) includes a number of magazines (1, 3), each magazine storing a different type of container blank (2, 4). There are further insert magazines (9, 10, 11, 12), each storing a different type of container insert suitable for use with at least one of the container types. The apparatus further includes a forming station (6) that selects a blank of one container type, forms the container from the blank, and, if required, inserts one of the container inserts. The apparatus is flexible as it may switch from manufacture of a first type of container to a second type of container without requiring physical modification, or any significant delay.
Patent NZ-534987-A (NZ)
Title: Mobile device memory rewriting apparatus that checks there is enough battery power to complete the update(s)
Inventor: NOHNO MASAKI
IPC: G06F1/32
Filed: 2003-01-24
Abstract: A memory rewriting apparatus to enable rewriting data stored in a memory of the cellular terminal completely without failure due to low battery power. According to the model type and the version number of data stored for each area, a memory area requiring update is specified. A battery amount required for rewrite/update the data of the memory area specified is calculated. The calculated battery amount is compared to the acquired current battery remaining amount and if the battery remaining amount is sufficient, data for the specified memory area is transmitted to the cellular telephone and the memory area to be updated is specified.
Patent NZ-535602-A (NZ)
Title: Enhanced silk exsertion under stress in Zea mays plants
Inventor: ZINSELMEIER CHRISTOPHER
IPC: C07K14/415
Filed: 2003-04-08
Abstract: A method for enhancing silk exsertion in a Zea mays plant under stress comprises transforming the plant with a construct comprising a silk-specific or silk-preferred promoter operably linked to a polynucleotide encoding a polypeptide which increases the rate or degree of cell expansion. Preferably the polynucleotide encodes an expansin protein, aquaporin, sucrose symporter, invertase, sodium antiporter or vacuolar pyrophosphatase. Also described are nucleic acid, host cells and transgenic plants
Patent NZ-537829-A (NZ)
Title: Parenteral formulations containing a rapamycin hydroxyester
Inventor: RUBINO JOSEPH T
IPC: A61K31/4745
Filed: 2003-07-25
Abstract: Parenteral formulations of rapamycin 42-ester with 3-hydroxy-2(hydroxymethyl)-2-methylpropionic acid (CCI-779).
Patent NZ-539975-A (NZ)
Title: Hydroentangling using a fabric having flat filaments
Inventor: LEVINE MARK J
IPC: D03D15/292
Filed: 2003-12-08
Abstract: A fabric is disclosed incorporating flattened filaments for use as a support fabric in producing a nonwoven product by a hydroentangling process, and a hydroentangling method employing such a fabric.
Patent NZ-540726-A (NZ)
Title: Cogeneration system
Inventor: CLUCAS DONALD MURRAY
Filed: 2005-06-13
Abstract: A cogeneration system including: a combustion chamber having a burner for supplying heat to an external combustion engine; a generator driven by the engine for producing electricity; a first exhaust passage for exhaust gases, from the combustion chamber to an exhaust gas heat exchanger for supplying heat to an external thermal load, arranged so that combustion gases flow over hot end heat exchanger(s) of the external combustion engine; a second exhaust passage from the combustion chamber to an exhaust gas heat exchanger, via which combustion gases bypass hot end heat exchanger(s) of the external combustion engine; an exhaust bypass valve associated with the second exhaust passage and operable to open the second exhaust passage; and a fan for drawing exhaust gases through at least the second exhaust passage.